Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq

Calithera Biosciences

25/01/2023 11:23

Jan 25 (Reuters) - Calithera Biosciences Inc  CALA.O :
    * CALITHERA BIOSCIENCES -  ON JANUARY 24, 2023 RECEIVED
NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
    * CALITHERA BIOSCIENCES INC - TRADING OF COMMON STOCK WILL
BE
SUSPENDED AS OF OPENING OF BUSINESS ON FEBRUARY 2, 2023

Further company coverage:  CALA.O 
 ((Reuters.Briefs@thomsonreuters.com;))